Defective Products & Drug Recalls in VA Archives - Page 61 of 68 - Shapiro, Washburn & Sharp

False Marketing Prompts FDA to Warn to Drug Manufacturers

The Wall Street Journal has reported that the U.S. Food and Drug Administration has issued warnings to the makers and marketeers of high blood pressure medication Adcirca (tadalafil) for issuing marketing materials containing misleading information. In the United States, United Therapeutics markets and develops Adcirca. Eli Lilly & Co. markets and develops the product outside…

read more